NEI Research News

Research funded by the National Eye Institute offers insight into what is happening in our brains when our working memory must use its limited resources to remember multiple things.

Brown University researchers have identified a promising new approach that may help to restore vision in people affected by macular degeneration and other retinal disorders.

New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting vision from childhood.

New CRISPR gene editing approach may also be useful for treating other inherited diseases, such as cystic fibrosis and familial hypercholesterolemia

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Northwestern study finds ‘alarming’ disparities — lack of glaucoma care can lead to blindness.

Researchers have developed lab-grown pig retinal organoids to test stem cell replacement therapies for diseases that damage the eye's light-sensing photoreceptors.

Herpes stromal keratitis is a debilitating vision condition that occurs in response to a herpes infection in the eye.

A clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients, and there was a high proportion of complete or partial success.

A team led by researchers at Mount Sinai has identified in mice a potential therapeutic target for dry eye disease.